T2 Biosystems, Inc.
TTOO
$0.1255
-$0.006-4.56%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.69% | -5.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.69% | -5.29% | |||
| Cost of Revenue | 11.43% | -23.59% | |||
| Gross Profit | -16.07% | 30.02% | |||
| SG&A Expenses | -1.74% | -18.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.37% | -21.38% | |||
| Operating Income | -6.12% | 24.01% | |||
| Income Before Tax | -12.88% | 33.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.88% | 33.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.88% | 33.77% | |||
| EBIT | -6.12% | 24.01% | |||
| EBITDA | -6.19% | 24.11% | |||
| EPS Basic | 11.09% | 76.06% | |||
| Normalized Basic EPS | 11.07% | 76.06% | |||
| EPS Diluted | 11.09% | 76.06% | |||
| Normalized Diluted EPS | 11.07% | 76.06% | |||
| Average Basic Shares Outstanding | 26.94% | 176.66% | |||
| Average Diluted Shares Outstanding | 26.94% | 176.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
